E
Biodesix, Inc. BDSX
$0.3533 $0.00551.58% NASDAQ
Recommendation
Prev Close
$0.3478
Volume
1,045,173
Avg Vol (90D)
453,561
Market Cap
$50.77M
Dividend & Yield
--
52-Week Range
$0.34 - $2.04
P/E (TTM)
--
EPS (TTM)
-$0.3515
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
DocGo Inc. (DCGO) Reports Q1 Loss, Misses Revenue Estimates
5/8/2025 - Zacks Investment Research
Biodesix, Inc. (NASDAQ:BDSX) Receives Average Rating of "Buy" from Analysts
5/1/2025 - MarketBeat
Canaccord Genuity Group Issues Pessimistic Forecast for Biodesix (NASDAQ:BDSX) Stock Price
5/1/2025 - MarketBeat
GeneDx Holdings Corp. (WGS) Q1 Earnings and Revenues Surpass Estimates
4/30/2025 - Zacks Investment Research
Biodesix (BDSX) Target Price Reduced by Canaccord Amid Market Challenges BDSX Stock News
4/29/2025 - GuruFocus
Biodesix price target lowered to $2.50 from $3.50 at Canaccord
4/29/2025 - The Fly
Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025
4/29/2025 - GuruFocus
Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025 BDSX Stock News
4/29/2025 - GuruFocus
Biodesix to Report First Quarter 2025 Financial Results on May 13, 2025
4/29/2025 - Globe Newswire
Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates
4/28/2025 - Zacks Investment Research
Avantor, Inc. (AVTR) Q1 Earnings Meet Estimates
4/25/2025 - Zacks Investment Research
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, ...
4/23/2025 - GuruFocus
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
4/23/2025 - Globe Newswire
Investors Give Biodesix, Inc. (NASDAQ:BDSX) Shares A 33% Hiding
4/19/2025 - Simply Wall St
Biodesix Announces Board Member Resignations
4/17/2025 - TipRanks Financial Blog
Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Expands By 29.5%
4/2/2025 - Ticker Report
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Up 29.5% in March
4/1/2025 - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Shares Acquired by AIGH Capital Management LLC
3/31/2025 - MarketBeat
AIGH Capital Management LLC Boosts Stake in Biodesix, Inc. (NASDAQ:BDSX)
3/30/2025 - Ticker Report
Perkins Capital Management Inc. Increases Holdings in Biodesix, Inc. (NASDAQ:BDSX)
3/25/2025 - MarketBeat
Short Interest in Biodesix, Inc. (NASDAQ:BDSX) Rises By 24.6%
3/18/2025 - Ticker Report
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Up 24.6% in February
3/17/2025 - MarketBeat
What is William Blair's Forecast for Biodesix Q1 Earnings?
3/7/2025 - MarketBeat
Biodesix (BDSX) Upgraded to Buy: What Does It Mean for the Stock?
3/6/2025 - Zacks Investment Research
Research Analysts Set Expectations for Biodesix Q1 Earnings
3/6/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$71.32M
EBITDA (TTM)
-$28.49M
EBIT (TTM)
-$34.26M
Net Income (TTM)
-$42.93M
Balance Sheet
Total Assets (Q)
$97.24M
Total Debt (Q)
$126.73M
Total Liabilities (Q)
$76.37M
Book Value Per Share (Q)
$0.1435
Cash Flow
Cash from Operations (TTM)
-$48.65M
Cash from Investing (TTM)
-$3.44M
Cash from Financing (TTM)
$52.05M
Net Change in Cash (TTM)
-$39.00K
Filings
Filing Date
Monday, March 3, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
0.71
7-Day Total Return
-33.83%
30-Day Total Return
-50.39%
60-Day Total Return
-62.38%
90-Day Total Return
-76.11%
Year to Date Total Return
-76.11%
1-Year Total Return
-77.19%
2-Year Total Return
-77.48%
3-Year Total Return
-80.78%
5-Year Total Return
--
52-week Low
May 08, 2025 - $0.34
52-week High
Aug 30, 2024 - $2.04
Valuation
Market Cap
$50.77M - Micro Cap
Enterprise Value
$87.91M
Price/Sales (TTM)
0.71
Price/Book (Q)
2.42
Dividends and Shares
Shares Outstanding
146.60M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.biodesix.com
Phone Number
303 417 0500
Address
919 West Dillon Road
Louisville, CO 80027
Country
United States
Year Founded
2005
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Biodesix, Inc. operates as a diagnostic solutions company. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests markets as Nodify Lung Nodule Risk Assessment... more
NASDAQ 05/09/2025 11:46AM Eastern Quotes delayed